Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Selgas

Showing results (121-130 of 182) with videos related to

Pageof 19
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1994
Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term studyR Selgas, M J Fernandez-Reyes, E Bosque, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
An analysis of adequacy of dialysis in a selected population on CAPD for over 3 years: the influence of urea and creatinine kineticsR Selgas, M A Bajo, M J Fernandez-Reyes, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|October 30, 2008
[Animal models of peritoneal dialysis: relevance, difficulties, and future]G T González-Mateo, J Loureiro-Alvarez, S Rayego-Mateos, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Treatment of the anemia with human recombinant erythropoietin in CAPD patientsB Miranda, R Selgas, C Riñon, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 29, 2000
Ex vivo proliferation of mesothelial cells directly obtained from peritoneal effluent: its relationship with peritoneal antecedents and functional parametersC Díaz, R Selgas, M A Castro, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|May 24, 2000
[Type I early failure of peritoneal ultrafiltration (UF)]R Selgas, M A Bajo, A Cirugeda, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1991
Medium term response to H-R erythropoietin in CAPD patients: the influence of erythropoietin plasmatic levels and the effects on peritoneal transport capacityM A Bajo, R Selgas, B Miranda, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 24, 2001
Risk factors responsible for ultrafiltration failure in early stages of peritoneal dialysisR Selgas, M A Bajo, M J Castro, et al.
Clinical Nephrology|May 1, 1983
Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPDM E Martínez, J L Miguel, P Gómez, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 18, 2000
Protein-losing enteropathy is associated with peritoneal functional abnormalities in peritoneal dialysis patientsA Aguilera, M A Bajo, R Codoceo, et al.
Pageof 19

Showing results (121-130 of 182) with videos related to

Sort By:
Pageof 19
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1994
Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term studyR Selgas, M J Fernandez-Reyes, E Bosque, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
An analysis of adequacy of dialysis in a selected population on CAPD for over 3 years: the influence of urea and creatinine kineticsR Selgas, M A Bajo, M J Fernandez-Reyes, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|October 30, 2008
[Animal models of peritoneal dialysis: relevance, difficulties, and future]G T González-Mateo, J Loureiro-Alvarez, S Rayego-Mateos, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Treatment of the anemia with human recombinant erythropoietin in CAPD patientsB Miranda, R Selgas, C Riñon, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 29, 2000
Ex vivo proliferation of mesothelial cells directly obtained from peritoneal effluent: its relationship with peritoneal antecedents and functional parametersC Díaz, R Selgas, M A Castro, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|May 24, 2000
[Type I early failure of peritoneal ultrafiltration (UF)]R Selgas, M A Bajo, A Cirugeda, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1991
Medium term response to H-R erythropoietin in CAPD patients: the influence of erythropoietin plasmatic levels and the effects on peritoneal transport capacityM A Bajo, R Selgas, B Miranda, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 24, 2001
Risk factors responsible for ultrafiltration failure in early stages of peritoneal dialysisR Selgas, M A Bajo, M J Castro, et al.
Clinical Nephrology|May 1, 1983
Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPDM E Martínez, J L Miguel, P Gómez, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 18, 2000
Protein-losing enteropathy is associated with peritoneal functional abnormalities in peritoneal dialysis patientsA Aguilera, M A Bajo, R Codoceo, et al.
Pageof 19